Consequently, in this study we sought to characterise several MRC-related parameters, including MRC complex III targeted drug sensitivity, in adult glioblastoma patient biopsy-derived cell cultures, to determine whether there was an association with F18L-carriers and non-carriers in vitro. This evidence concerns the gene CD200 and glioblastoma.